The kidney care services provider has now collected more than $105m to date, Optum Ventures co-leading a round also featuring Blue Venture Fund.

Optum Ventures, the strategic investment arm of healthcare services provider Optum, co-led a $64m series C round for US-based kidney care provider Somatus on Tuesday. Longitude Capital and Deerfield Management co-led the round, which included Blue Venture Fund, the investment vehicle for health insurance group BlueCross BlueShield Association, in addition to Flare Capital and Town…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.